No coverage is required under §§ 58-17-100 to 58-17-106, inclusive, for the following:
(1) Any drug that has not been fully licensed or approved by the FDA;
(2) The use of any drug if the FDA has determined that use to be contraindicated; or
(3) Any experimental drug not otherwise approved for any indication by the FDA.